Open source matching of a patient's tumor biomarkers to the clinical trials most likely to fit their disease.
Consented intake · your records travel with you · nothing moves without your sign-off
MatchMiner.org is an open source platform from DFCI focused on matching patients to clinical trials. Using the biomarker profile from a patient's test data, it recommends the treatment and trial options with the most likely effective response. It is for patients and clinicians who want treatment ideas grounded in broad global thinking, plus a sense of confidence in the predicted outcome.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how MatchMiner.org (open source - clinical trials - DFCI) handles billing.
We don't have confirmed insurance details for MatchMiner.org (open source - clinical trials - DFCI) yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in MatchMiner.org's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Other providers in similar categories.
Provide a trusted medical context for personalized experiments; contribute to research that will benefit others and hope that new treatments will be identified in time that may help me.
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
Matches your tumor's biomarkers to the therapies most likely to work for you — mapping your molecular profile to targeted and approved options.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.